Stop spending 40% of your time searching fragmented drug data. PharmaCopilot delivers instant, sourced answers — built on 2M+ verified pharmaceutical documents.
St. John's Wort reduces apixaban levels by up to 50%, significantly increasing thromboembolism risk.
Healthcare professionals spend 30–40% of their time on information retrieval instead of patient care.
2M+ drug products across 90+ countries — each with complex interactions, contraindications, and dosage guidelines that change constantly.
Juggling PILs, SmPCs, alert databases, and shortage lists at the point of care wastes time that should go to patients.
Daily updates to drug information, recalls, and safety alerts across multiple jurisdictions — impossible to track manually.
PharmaCopilot is a conversational AI assistant built exclusively on myHealthbox's verified pharmaceutical data — not the open web, not generic training data.
Every answer is traceable to an official, regulator-approved source. No hallucinations. No liability surprises. Designed for EU AI Act compliance from the ground up.
This is what separates PharmaCopilot from ChatGPT or any generic AI: the quality and provenance of the data it reasons over.
Natural language queries against the full myHealthbox corpus. Ask anything — get sourced, traceable answers in seconds.
Paste a patient's full medication list. Get instant interaction analysis with severity scoring and clinical recommendations.
Real-time shortage alerts with AI-suggested therapeutically equivalent alternatives, verified against live availability data.
Patient asks in Arabic? You see the clinical summary in your language while they receive the answer in theirs.
Daily AI-curated briefing of relevant updates, recalls, and label changes for the products you dispense and prescribe most.
Pharmacists, physicians, and nurses who need fast, reliable drug information at the point of care — in any language.
Teams managing formularies, medical information, and safety monitoring across large product portfolios.
Professionals tracking label changes, submissions, recalls, and compliance across multiple EU jurisdictions.
PharmaCopilot is in active development. Register now and we'll invite you to join the beta programme — at no cost — before public launch.
We'll be in touch with your early access invitation shortly. Thank you for your interest in PharmaCopilot.